Zydus receives final approvals from USFDA for Ivermectin Tablets USP
Ivermectin Tablets USP, 3 mg, are prescription anti-parasitic medications primarily indicated for treating parasitic worm infections in humans
Ivermectin Tablets USP, 3 mg, are prescription anti-parasitic medications primarily indicated for treating parasitic worm infections in humans
The TacroType test provides actionable genetic insights to help clinicians understand how individual patients metabolize tacrolimus
The new patents cover critical advancements in cochlear implant technology
The program offers selected participants advanced access to Promise Bio’s broad-epiproteomic platform
The collaboration merges biomodal’s 5-base and 6-base sequencing solutions, duet +modC and duet evoC
One of India’s top integrated contract research, development, and manufacturing organizations (CRDMOs) is on a hiring spree
If approved, DTX401 would be the first treatment to address the disease at its root cause
This multi-year CDMO agreement involves significant, ongoing manufacturing for a global pharmaceutical major
Our vision is to position India not just as a consumer of advanced simulation technologies but as a creator and exporter of them
Expansion at the Oss (NL) site adds capacity and R&D capabilities, supporting the development and manufacturing of ADCs and other novel bioconjugates from First-in-Human to commercialization
Subscribe To Our Newsletter & Stay Updated